1. Transpharmation Ltd. Announces Strategic Acquisition of Saretius Ltd.
  2. Society for Neuroscience 2024
  3. Neuropsychiatric Drug Development Summit
  4. Safety Pharmacology Society (SPS)
  5. ILAE - 15th European Epilepsy congress
  6. Kansas City Animal Health Corridor
  7. IASP 2024 World Congress on Pain
  8. AAIC 2024
  9. OARSI 2024
  10. Western Veterinary Conference
  11. AD/PD 2024
  12. Animal Health, Nutrition & Technology Innovation
  13. VMX 2024
  14. American College of Toxicology
  15. Society for Neuroscience 2023
  16. CNS Summit
  17. Canine Conference 2023
  18. ELRIG Drug Discovery
  19. Animal Health, Nutrition & Technology Innovation - Asia
  20. BioJapan 2023
  21. 2023 SPS Annual Meeting
  22. Breaking New Ground: Unleashing Canine EEG Capabilities for Enhanced Research at Transpharmation Canada.
  23. The 6th Animal Health, Nutrition and Technology Innovation Meeting
  24. NeuPSIG 2023
  25. International League Against Epilepsy
  26. The 2023 Animal Health Summit
  27. Best Poster Winner!
  28. Alzheimer's Association International Conference
  29. Transpharmation Collaborates With Artelo Biosciences To Support Development Of Neuropathic Pain Treatment
  30. 12th European Zebrafish Meeting
  31. Transpharmation and Veterinary Health Research Centers Partnership
  32. Published!
  33. The Neuro4D Conference
  34. Psychedelic Therapeutics and Drug Development Conference
  35. New poster added to our publications page, recently presented at FENS
  36. New poster added to our publications page, recently presented at ADPD!
  37. FENS Regional Meeting 2023
  38. Neuroimmunology Drug Development Summit
  39. New clients, different time zones
  40. AD/PD 2023
  41. OARSI World Congress
  42. Veterinary Meeting and Expo
  43. Dr. Pabitra H. Patra paper published in PAIN
  44. New published work!
  45. Name change announcement, news from the CEO
  46. CNS Therapeutic Xchange Europe 2022, Zurich - 24th November
  47. Society for Neuroscience 2022, November 12-16, California
  48. Here, there and everywhere - we love meeting up with you!
  49. ECNP Congress, 15th-18th October - Vienna, Austria
  50. Recent collaborative work published by Frontiers in Molecular Neuroscience
  51. Global representation meeting the needs of our worldwide client base
  52. Animals in scientific research, 7th Annual Conference, by PolLASA. 12-14th September, Warsaw, Poland
  53. The Safety Pharmacology Society Annual Meeting - September 11-14, Montréal, Canada
  54. HubXchange's US West Coast CNS Therapeutics Meeting - 29th September
  55. IASP World Conference on Pain - Toronto, Canada, 19th - 23rd September
  56. Rapid access to canine preclinical studies and leading PK expertise
  57. Collaboration between Zebrafish Lab and Transpharmation continues
  58. 5th Polish Zebrafish Society Workshop in Lublin (Poland) 29th June - 1st July
  59. Progressive Ratio Task reveals effectiveness of single-dose psilocybin
  60. BPS live! Rapid acting antidepressants, from ketamine to psychedelics TUESDAY 10TH, 17TH AND 24TH MAY, 2PM (BST)
  61. SMi’s 22nd Annual Conference; Pain Therapeutics, 4 - 5 May, 2022, London
  62. The Neuro4D Conference 2022, Mainz, Germany, 16th - 17th May 2022
  63. Long term and delayed effects of psychedelics in preclinical models
  64. ADPD, 16th International Conference on Alzheimer's Disease and Parkinson's Disease – 15 - 20 March 2022
  65. Transpharmation’s Facilities Management Company receive AAALAC accreditation
  66. Fierce Biotech report on Transpharmation and InterVivo's joint venture
  67. InterVivo Solutions and Transpharmation join forces as sister companies
  68. Zebrafish as a translational model for neuroscience research
  69. HubXchange - CNS Therapeutics Xchange Europe 2021 – 2nd December 2021
  70. The Society for Neuroscience 50th Annual Meeting will be fully virtual - 8-11 November
  71. 34th ECNP Congress Hybrid - Lisbon, Portugal - 2nd - 5th October 2021
  72. Neurex Neuroforum 2021
  73. Cannabinoids and Psychedelics; Neuroscience Ireland Meeting 2021 - 9th-10th September 2021
  74. UK scientists at Transpharmation and Clerkenwell Health combine lab and human trials, as psilocybin offers hope for people with an end-of-life diagnosis
  75. FENS Regional Meeting (FRM) - 25-27 August 2021
  76. InterVivo Solutions Provides Update on Cooperative Psychedelics Evaluation Platform (COPE)
  77. 31st Annual International Cannabinoid Research Society (ICRS) Virtual Symposium on Cannabinoids - 21-24 June 2021
  78. Transpharmation’s pain expertise recognised
  79. Let us inspire you!
  80. Transpharmation Ireland gains Green Labs certification
  81. ICNMD – 16th International Congress on Neuromuscular Diseases Digital 2021 - 21-22 & 28-29 May 2021
  82. HubXchange's US East Coast CNS Therapeutics e-Xchange Virtual meeting - 24-26 May 2021
  83. SMi - 21st Annual Conference Pain Therapeutics Virtual conference - 10-11 of May 2021
  84. 3rd Annual Neuroimmunology Drug Development Summit 2021 Virtual Conference – 27-29 April 2021
  85. BNA 2021 - British Neuroscience Association - Festival of Neuroscience 2021 Virtual Conference 12-15 April 2021
  86. “Companies have no borders”, said Mark Duxon, CEO of Transpharmation
  87. ADPD, 15th International Conference on Alzheimer's Disease and Parkinson's Disease – 9-14 March 2021
  88. New Laboratory
  89. InterVivo Solutions Issued Institutional Cannabis Research License By Health Canada
  90. ASENT - American Society of Experimental Neurotherapeutics 2021 Virtual Conference 22-25 of February 2021
  91. Peer Review Journal Publication
  92. Society for Neuroscience (SfN) digital event 11-13th January 2021
  93. Neuronus 2020 IBRO neuroscience forum - 8th - 11th December 2020
  94. Transpharmation’s expansion to world class facilities!
  95. Young Investigator Symposium, 6th November 2020
  96. Inflammasome Therapeutics Summit - 4th - 6th November 2020
  97. Ten year anniversary!
  98. Alzheimer’s Drug Discovery Foundation (ADDF) - 5th and 6th October 2020
  99. WMS virtual conference - 28th September – 2nd October 2020
  100. IASP